ABOUT GOLDMAN BIO
Goldman Bio specializes in the development, integration and commercialization of Israeli Life Science technologies, with emphasis on the field of personalized medicine and focusing on cancer.
The field of personalized medicine is emerging as the future of medical treatment. This approach offers new solutions to medical problems and innovative ways to implement existing solutions.
The nature of the Goldman Bio’s portfolio companies, already dealing with different aspects of personalized medicine (from diagnostics to health care technologies) creates a network of companies with complementary technologies. The Group’s management team, its colleagues, partners and advisors have extensive and proven experience, and possess the combined ability to identify and select breakthrough technologies in the Group’s specialized fields and develop them into valuable commercial assets.
This expertise and specialization have enabled the Group to establish a powerful and proficient infrastructure for the development, integration and commercialization of Israeli cancer research technologies whilst achieving significant economic value on behalf of our stakeholders.
our vision
Goldman Bio’s vision is to provide a technology transfer infrastructure for Israeli technologies in the fields of Life Sciences and Personalized Medicine.
To achieve this vision, we have developed a unique structured management methodology that identifies and promotes promising technologies from concept to commercialization within the group’s active structure.
OUR LEADERSHIP
